Compare Biocon with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs J.B.CHEMICALS - Comparison Results

BIOCON      Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON J.B.CHEMICALS BIOCON /
J.B.CHEMICALS
 
P/E (TTM) x 32.1 43.8 73.3% View Chart
P/BV x 3.8 8.2 46.9% View Chart
Dividend Yield % 0.3 0.1 178.1%  

Financials

 BIOCON    J.B.CHEMICALS
EQUITY SHARE DATA
    BIOCON
Mar-19
J.B.CHEMICALS
Mar-18
BIOCON /
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs707363 194.8%   
Low Rs554255 217.2%   
Sales per share (Unadj.) Rs91.9169.1 54.3%  
Earnings per share (Unadj.) Rs16.716.6 100.7%  
Cash flow per share (Unadj.) Rs24.223.4 103.2%  
Dividends per share (Unadj.) Rs1.002.00 50.0%  
Dividend yield (eoy) %0.20.6 24.5%  
Book value per share (Unadj.) Rs101.6172.5 58.9%  
Shares outstanding (eoy) m600.0083.57 718.0%   
Bonus / Rights / Conversions -BB-  
Price / Sales ratio x6.91.8 375.5%   
Avg P/E ratio x37.718.6 202.7%  
P/CF ratio (eoy) x26.113.2 197.6%  
Price / Book Value ratio x6.21.8 346.3%  
Dividend payout %6.012.0 49.7%   
Avg Mkt Cap Rs m378,33025,827 1,464.8%   
No. of employees `0006.13.8 162.5%   
Total wages/salary Rs m11,6532,511 464.1%   
Avg. sales/employee Rs Th8,994.33,747.4 240.0%   
Avg. wages/employee Rs Th1,900.7665.7 285.5%   
Avg. net profit/employee Rs Th1,635.3367.8 444.7%   
INCOME DATA
Net Sales Rs m55,14414,135 390.1%  
Other income Rs m1,444366 394.8%   
Total revenues Rs m56,58814,501 390.2%   
Gross profit Rs m15,8832,178 729.1%  
Depreciation Rs m4,478570 786.0%   
Interest Rs m70935 2,031.5%   
Profit before tax Rs m12,1401,940 625.9%   
Minority Interest Rs m90-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,123552 384.4%   
Profit after tax Rs m10,0261,387 722.8%  
Gross profit margin %28.815.4 186.9%  
Effective tax rate %17.528.5 61.4%   
Net profit margin %18.29.8 185.3%  
BALANCE SHEET DATA
Current assets Rs m48,22810,470 460.6%   
Current liabilities Rs m30,3762,749 1,105.0%   
Net working cap to sales %32.454.6 59.3%  
Current ratio x1.63.8 41.7%  
Inventory Days Days6855 123.7%  
Debtors Days Days8678 110.1%  
Net fixed assets Rs m64,1305,811 1,103.6%   
Share capital Rs m3,000167 1,795.3%   
"Free" reserves Rs m57,98014,248 406.9%   
Net worth Rs m60,98014,416 423.0%   
Long term debt Rs m15,7660-   
Total assets Rs m121,92417,649 690.8%  
Interest coverage x18.156.6 32.0%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.50.8 56.5%   
Return on assets %8.88.1 109.3%  
Return on equity %16.49.6 170.9%  
Return on capital %16.813.7 122.3%  
Exports to sales %28.10-   
Imports to sales %18.90-   
Exports (fob) Rs m15,506NA-   
Imports (cif) Rs m10,399NA-   
Fx inflow Rs m15,5066,164 251.6%   
Fx outflow Rs m10,3991,334 779.3%   
Net fx Rs m5,1074,829 105.7%   
CASH FLOW
From Operations Rs m11,5461,231 938.3%  
From Investments Rs m-7,138-208 3,430.1%  
From Financial Activity Rs m-2,417-595 406.1%  
Net Cashflow Rs m2,103427 492.4%  

Share Holding

Indian Promoters % 40.4 55.4 72.9%  
Foreign collaborators % 20.6 0.3 6,866.7%  
Indian inst/Mut Fund % 8.4 3.4 247.8%  
FIIs % 10.7 3.9 274.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 37.0 53.8%  
Shareholders   109,995 30,437 361.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   DR. DATSONS LABS  DISHMAN PHARMA  UNICHEM LAB  JUBILANT PHARMOVA   AJANTA PHARMA  

Compare BIOCON With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty End Flat; Asian Paints, UPL & ITC Among Top Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

BIOCON Announces Quarterly Results (3QFY21); Net Profit Down 19.7% (Quarterly Result Update)

Jan 25, 2021 | Updated on Jan 25, 2021

For the quarter ended December 2020, BIOCON has posted a net profit of Rs 2 bn (down 19.7% YoY). Sales on the other hand came in at Rs 19 bn (up 5.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY21); Net Profit Down 23.9% (Quarterly Result Update)

Oct 29, 2020 | Updated on Oct 29, 2020

For the quarter ended September 2020, BIOCON has posted a net profit of Rs 2 bn (down 23.9% YoY). Sales on the other hand came in at Rs 17 bn (up 11.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

BIOCON Announces Quarterly Results (3QFY20); Net Profit Up 1.2% (Quarterly Result Update)

Jan 24, 2020 | Updated on Jan 24, 2020

For the quarter ended December 2019, BIOCON has posted a net profit of Rs 2 bn (up 1.2% YoY). Sales on the other hand came in at Rs 17 bn (up 13.5% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (2QFY20); Net Profit Down 30.5% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, BIOCON has posted a net profit of Rs 3 bn (down 30.5% YoY). Sales on the other hand came in at Rs 16 bn (up 19.0% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

More Views on News

Most Popular

Is Intraday Trading For You?(Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


May 14, 2021 (Close)

TRACK BIOCON

BIOCON - DISHMAN PHARMA COMPARISON

COMPARE BIOCON WITH

MARKET STATS